
The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice
Keywords: AGE; advanced glycation end products; BRB; blood-retinal barrier; BSA; bovine serum albumin; DR; diabetic retinopathy; FBS; fetal bovine serum; FITC; fluorescein isothiocyanate; mLDL; modified low-density lipoprotein; MCP1; monocyte chemoattractant protei